Differences between invasive lobular and invasive ductal carcinoma of the breast: results and therapeutic implications (Q26740072)

invasive ductal carcinoma

title

Differences between invasive lobular and invasive ductal carcinoma of the breast: results and therapeutic implications (English)

0 references

main subject

1 reference

inferred from title

author

Romualdo Barroso-Sousa

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27482285 AND SRC:MED&resulttype=core&format=json

11 June 2020

author name string

Otto Metzger-Filho

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27482285 AND SRC:MED&resulttype=core&format=json

Therapeutic advances in medical oncology

11 June 2020

language of work or name

English

0 references

publication date

July 2016

0 references

published in

2 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27482285 AND SRC:MED&resulttype=core&format=json

11 June 2020

volume

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27482285 AND SRC:MED&resulttype=core&format=json

11 June 2020

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27482285 AND SRC:MED&resulttype=core&format=json

11 June 2020

page(s)

261-266

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27482285 AND SRC:MED&resulttype=core&format=json

Trastuzumab after adjuvant chemotherapy in HER2-positive breast cancer

11 June 2020

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4952020

Comprehensive Molecular Portraits of Invasive Lobular Breast Cancer

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4952020

Chromosome-wide mapping of estrogen receptor binding reveals long-range regulation requiring the forkhead protein FoxA1

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4952020

Genomic Characterization of Primary Invasive Lobular Breast Cancer

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4952020

Comparison of Oncotype DX Recurrence Score by Histologic Types of Breast Carcinoma

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4952020

Is There a Role for Oncotype Dx Testing in Invasive Lobular Carcinoma?

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4952020

Relative Effectiveness of Letrozole Compared With Tamoxifen for Patients With Lobular Carcinoma in the BIG 1-98 Trial

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4952020

Invasive lobular carcinoma of the breast: morphology, biomarkers and 'omics

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4952020

Differential expression of estrogen receptor α, β1, and β2 in lobular and ductal breast cancer

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4952020

Invasive lobular carcinoma cell lines are characterized by unique estrogen-mediated gene expression patterns and altered tamoxifen response

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4952020

Clinical benefit from neoadjuvant chemotherapy in oestrogen receptor-positive invasive ductal and lobular carcinomas

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4952020

GATA3 acts upstream of FOXA1 in mediating ESR1 binding by shaping enhancer accessibility

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4952020

FOXA1 is a key determinant of estrogen receptor function and endocrine response

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4952020

Lobular breast carcinoma and its variants

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4952020

ERRgamma mediates tamoxifen resistance in novel models of invasive lobular breast cancer

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4952020

A comparison of letrozole and tamoxifen in postmenopausal women with early breast cancer

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4952020

Invasive lobular carcinoma classic type: response to primary chemotherapy and survival outcomes

28 September 2017

1 reference

https://api.crossref.org/works/10.1177/1758834016644156

Treatment with trastuzumab for 1 year after adjuvant chemotherapy in patients with HER2-positive early breast cancer: a 4-year follow-up of a randomised controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/1758834016644156

Invasive lobular breast cancer: subtypes and outcome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/1758834016644156

Trends in incidence rates of invasive lobular and ductal breast carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/1758834016644156

Lobular histology and response to neoadjuvant chemotherapy in invasive breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/1758834016644156

Genomic grade adds prognostic value in invasive lobular carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/1758834016644156

Magnitude of trastuzumab benefit in patients with HER2-positive, invasive lobular breast carcinoma: results from the HERA trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/1758834016644156

Invasive lobular carcinoma of the breast: response to hormonal therapy and outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/1758834016644156

Utility of Oncotype DX Risk Assessment in Patients With Invasive Lobular Carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/1758834016644156

Association between standard clinical and pathologic characteristics and the 21-gene recurrence score in breast cancer patients: a population-based study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/1758834016644156

Response to neoadjuvant chemotherapy in lobular and ductal breast carcinomas: a retrospective study on 860 patients from one institution

21 January 2018

1 reference

https://pubmed.ncbi.nlm.nih.gov/27482285

12 December 2020

inferred from PubMed ID database lookup

Classical-type invasive lobular carcinoma with HER2 overexpression: clinical, histologic, and hormone receptor characteristics

1 reference

https://pubmed.ncbi.nlm.nih.gov/27482285

12 December 2020

inferred from PubMed ID database lookup

The poor responsiveness of infiltrating lobular breast carcinomas to neoadjuvant chemotherapy can be explained by their biological profile

1 reference

https://pubmed.ncbi.nlm.nih.gov/27482285

12 December 2020

inferred from PubMed ID database lookup

Identifiers

DOI

10.1177/1758834016644156

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27482285 AND SRC:MED&resulttype=core&format=json

11 June 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27482285 AND SRC:MED&resulttype=core&format=json

11 June 2020

PubMed publication ID

27482285

1 reference